TrialJournal of Zhejiang University. Science. B

Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablation.

Jun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.